Corneal Transplant Market is Expected to Grow at a CAGR over 11.20% from 2023 to 2032

Pune, India, October, 2022 /MRFR Press Release/- Market Research Future has a half cooked research report on the global corneal transplant market. Corneal Transplant Market is projected to reach USD 1.04 Billion by 2032, at CAGR 11.20% during the forecast period 2023-2032.

Market Highlights

Corneal transplant is a surgical procedure performed for the treatment of diseased cornea. Important indications for corneal transplant are keratoconus, keratitis, and corneal stromal dystrophies. The success rate of the treatment is found to be high, which support the market growth.

Rising prevalence of vision impartment and eye diseases such as diabetic retinopathy in geriatric population and diabetes across the globe drive the global Corneal Transplant Market. Additionally, rising awareness about organ donation and its importance, especially, in the developing countries likely to propel the market growth.

Cost of corneal transplant varies depending upon the region, availability of services, and skilled and qualified professionals. Major difference in the cost is observed, i.e. it is found to be high in the developed countries and low in developing countries still maintaining qualitative care. Therefore, cost effective of the treatment would affect the market growth.

Major Players in Corneal Transplant Market:

Some of the key players in the global market are CryoLife, Inc. (U.S.), Exactech, Inc. (U.S.), Köhler GmbH (U.S.), Lifeline Scientific (U.S), LifeCell Corporation (U.S.), Medtronic (U.S.), and Organogenesis Inc. (U.S.).

Regional Analysis

Europe is the largest market for corneal transplant which will exhibit positive growth in the near future due to rising prevalence of diabetes in the European countries and availability of treatment options. According to the World Health Organization, about 60 million Europeans have diabetes and its prevalence is relatively high among people over 25 years.

America is the second leading corneal transplant market across the globe owing to an increasing demand for corneal transplant surgery, and rising prevalence of eye diseases, and vision impairment among people in the U.S.

Asia Pacific market is expected to grow rapidly owing increasing prevalence of chronic diseases such as diabetes, diabetic retinopathy, and obesity. India is one of the international medical tourism destinations across the world, which further exhibits growth opportunities for the corneal transplant market due to availability of cost-effective treatment and rising success rates. Furthermore, the increasing healthcare expenditure by developing countries in Asia Pacific region also contributes to the market growth.

The Middle East & African market is growing steadily owing to rising demand for ophthalmic products and services, and available treatment options.

Segmentation

The global corneal transplant market is segmented on the basis of type, indication, and end user.

On the basis of type, the market is segmented into penetrating keratoplasty, endothelial keratoplasty, descemet stripping automated endothelial keratoplasty (DSAEK), corneal graft, corneal limbal stem cell transplant, and others.

On the basis of indication, the market is segmented into fungal corneal ulcer, bullous keratopathy, keratoconus, keratitis, corneal stromal dystrophies, and others.

On the basis of end user, the market is segmented into hospitals, eye clinics, and others.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Corneal Transplant Market Research Report